294 related articles for article (PubMed ID: 34195877)
1. Detection of ovarian cancer (± neo-adjuvant chemotherapy effects) via ATR-FTIR spectroscopy: comparative analysis of blood and urine biofluids in a large patient cohort.
Giamougiannis P; Morais CLM; Rodriguez B; Wood NJ; Martin-Hirsch PL; Martin FL
Anal Bioanal Chem; 2021 Aug; 413(20):5095-5107. PubMed ID: 34195877
[TBL] [Abstract][Full Text] [Related]
2. Raman spectroscopy of blood and urine liquid biopsies for ovarian cancer diagnosis: identification of chemotherapy effects.
Giamougiannis P; Silva RVO; Freitas DLD; Lima KMG; Anagnostopoulos A; Angelopoulos G; Naik R; Wood NJ; Martin-Hirsch PL; Martin FL
J Biophotonics; 2021 Nov; 14(11):e202100195. PubMed ID: 34296515
[TBL] [Abstract][Full Text] [Related]
3. Segregation of ovarian cancer stage exploiting spectral biomarkers derived from blood plasma or serum analysis: ATR-FTIR spectroscopy coupled with variable selection methods.
Lima KM; Gajjar KB; Martin-Hirsch PL; Martin FL
Biotechnol Prog; 2015; 31(3):832-9. PubMed ID: 25832726
[TBL] [Abstract][Full Text] [Related]
4. Fourier-transform infrared spectroscopy coupled with a classification machine for the analysis of blood plasma or serum: a novel diagnostic approach for ovarian cancer.
Gajjar K; Trevisan J; Owens G; Keating PJ; Wood NJ; Stringfellow HF; Martin-Hirsch PL; Martin FL
Analyst; 2013 Jul; 138(14):3917-26. PubMed ID: 23325355
[TBL] [Abstract][Full Text] [Related]
5. ATR-FTIR spectroscopy coupled with chemometric analysis discriminates normal, borderline and malignant ovarian tissue: classifying subtypes of human cancer.
Theophilou G; Lima KM; Martin-Hirsch PL; Stringfellow HF; Martin FL
Analyst; 2016 Jan; 141(2):585-94. PubMed ID: 26090781
[TBL] [Abstract][Full Text] [Related]
6. Vibrational biospectroscopy coupled with multivariate analysis extracts potentially diagnostic features in blood plasma/serum of ovarian cancer patients.
Owens GL; Gajjar K; Trevisan J; Fogarty SW; Taylor SE; Da Gama-Rose B; Martin-Hirsch PL; Martin FL
J Biophotonics; 2014 Apr; 7(3-4):200-9. PubMed ID: 24259229
[TBL] [Abstract][Full Text] [Related]
7. A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients.
Leandersson P; Åkesson A; Hedenfalk I; Malander S; Borgfeldt C
PLoS One; 2020; 15(10):e0240418. PubMed ID: 33075095
[TBL] [Abstract][Full Text] [Related]
8. A comparative analysis of different biofluids towards ovarian cancer diagnosis using Raman microspectroscopy.
Giamougiannis P; Morais CLM; Grabowska R; Ashton KM; Wood NJ; Martin-Hirsch PL; Martin FL
Anal Bioanal Chem; 2021 Jan; 413(3):911-922. PubMed ID: 33242117
[TBL] [Abstract][Full Text] [Related]
9. Highly accurate detection of ovarian cancer using CA125 but limited improvement with serum matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling.
Tiss A; Timms JF; Smith C; Devetyarov D; Gentry-Maharaj A; Camuzeaux S; Burford B; Nouretdinov I; Ford J; Luo Z; Jacobs I; Menon U; Gammerman A; Cramer R
Int J Gynecol Cancer; 2010 Dec; 20(9):1518-24. PubMed ID: 21370595
[TBL] [Abstract][Full Text] [Related]
10. HE4, Ca125 and ROMA algorithm for differential diagnosis between benign gynaecological diseases and ovarian cancer.
Ortiz-Muñoz B; Aznar-Oroval E; García García A; Covisa Peris A; Perez Ballestero P; Sanchez Yepes M; Garcia Lozano T; Illueca Ballester C; García Garcia E
Tumour Biol; 2014 Jul; 35(7):7249-58. PubMed ID: 24771264
[TBL] [Abstract][Full Text] [Related]
11. Spectrochemical differentiation of meningioma tumours based on attenuated total reflection Fourier-transform infrared (ATR-FTIR) spectroscopy.
Lilo T; Morais CLM; Ashton KM; Pardilho A; Davis C; Dawson TP; Gurusinghe N; Martin FL
Anal Bioanal Chem; 2020 Feb; 412(5):1077-1086. PubMed ID: 31865413
[TBL] [Abstract][Full Text] [Related]
12. Potential of mid-infrared spectroscopy as a non-invasive diagnostic test in urine for endometrial or ovarian cancer.
Paraskevaidi M; Morais CLM; Lima KMG; Ashton KM; Stringfellow HF; Martin-Hirsch PL; Martin FL
Analyst; 2018 Jun; 143(13):3156-3163. PubMed ID: 29878018
[TBL] [Abstract][Full Text] [Related]
13. Attenuated total reflection Fourier-transform infrared spectral discrimination in human bodily fluids of oesophageal transformation to adenocarcinoma.
Maitra I; Morais CLM; Lima KMG; Ashton KM; Date RS; Martin FL
Analyst; 2019 Dec; 144(24):7447-7456. PubMed ID: 31696873
[TBL] [Abstract][Full Text] [Related]
14. A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer - An international multicenter study in women with an ovarian mass.
Karlsen MA; Høgdall EV; Christensen IJ; Borgfeldt C; Kalapotharakos G; Zdrazilova-Dubska L; Chovanec J; Lok CA; Stiekema A; Mutz-Dehbalaie I; Rosenthal AN; Moore EK; Schodin BA; Sumpaico WW; Sundfeldt K; Kristjansdottir B; Zapardiel I; Høgdall CK
Gynecol Oncol; 2015 Sep; 138(3):640-6. PubMed ID: 26086566
[TBL] [Abstract][Full Text] [Related]
15. Brain tumour differentiation: rapid stratified serum diagnostics via attenuated total reflection Fourier-transform infrared spectroscopy.
Hands JR; Clemens G; Stables R; Ashton K; Brodbelt A; Davis C; Dawson TP; Jenkinson MD; Lea RW; Walker C; Baker MJ
J Neurooncol; 2016 May; 127(3):463-72. PubMed ID: 26874961
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Model of Serum miR-193a-5p, HE4 and CA125 Improves the Diagnostic Efficacy of Epithelium Ovarian Cancer.
Ren X; Zhang H; Cong H; Wang X; Ni H; Shen X; Ju S
Pathol Oncol Res; 2018 Oct; 24(4):739-744. PubMed ID: 29520570
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass.
Karlsen MA; Sandhu N; Høgdall C; Christensen IJ; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Lydolph M; Laursen IA; Høgdall EV
Gynecol Oncol; 2012 Nov; 127(2):379-83. PubMed ID: 22835718
[TBL] [Abstract][Full Text] [Related]
18. The Role of HE4, a Novel Biomarker, in Predicting Optimal Cytoreduction After Neoadjuvant Chemotherapy in Advanced Ovarian Cancer.
Plotti F; Scaletta G; Capriglione S; Montera R; Luvero D; Lopez S; Gatti A; De Cicco Nardone C; Terranova C; Angioli R
Int J Gynecol Cancer; 2017 May; 27(4):696-702. PubMed ID: 28406844
[TBL] [Abstract][Full Text] [Related]
19. Attenuated Total Reflectance-Fourier Transform Infrared (ATR-FTIR) Spectroscopy Discriminates the Elderly with a Low and High Percentage of Pathogenic CD4+ T Cells.
Praja RK; Wongwattanakul M; Tippayawat P; Phoksawat W; Jumnainsong A; Sornkayasit K; Leelayuwat C
Cells; 2022 Jan; 11(3):. PubMed ID: 35159268
[TBL] [Abstract][Full Text] [Related]
20. Serum HE4 Profile During Primary Chemotherapy of Epithelial Ovarian Cancer.
Hynninen J; Auranen A; Dean K; Lavonius M; Carpen O; Perheentupa A; Seppänen M; Grénman S
Int J Gynecol Cancer; 2011 Dec; 21(9):1573-8. PubMed ID: 21811175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
